Antares Pharma reported $1.14M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbott ABT:US $ 123M 11M
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Adma Biologics ADMA:US $ 3.3M 0.05M
Aerie Pharmaceuticals AERI:US $ 7.36M 0.24M
Ani Pharmaceuticals ANIP:US $ 2.5M 34K
Becton, Dickinson and BDX:US $ 111M 4M
Cerus CERS:US $ 1.28M 59K
Eli Lilly And LLY:US $ 83.6M 3.3M
Endo International Ordinary Shares ENDP:US $ 142.99M 1.35M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Pfizer PFE:US $ 325M 9M
Revance Therapeutics RVNC:US $ 1.57M 2K
Rockwell Medical RMTI:US $ 0.61M 0.03M
Sientra SIEN:US 2.03M 89K
Staar Surgical STAA:US $ 1000 0
Supernus Pharmaceuticals SUPN:US $ 5.92M 1.43M
Teva Pharmaceutical TEVA:IT 232M 8M
Teva Pharmaceutical Industries TEVA:US $ 232M 8M
Zogenix ZGNX:US $ 3.85M 0.06M